Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FANCY: Cyclosporine A and Natamycin for Fungal Keratitis
NCT06658002Phase 3Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Countries
- 2
01
Overview
A Phase 3 trial of cyclosporine 2% ophthalmic solution in fungal keratitis (FK), sponsored by University of California, San Francisco. Started Sep 2025; status: recruiting.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
fungal keratitis (FK)
Beyond the preview
Go deeper on NCT06658002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06658002.